Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 21 studies | 71% ± 19% | |
lung | 19 studies | 48% ± 18% | |
kidney | 9 studies | 34% ± 22% | |
liver | 7 studies | 58% ± 21% | |
bone marrow | 6 studies | 54% ± 24% | |
lymph node | 6 studies | 43% ± 16% | |
uterus | 6 studies | 58% ± 16% | |
intestine | 5 studies | 48% ± 13% | |
adipose | 4 studies | 36% ± 21% | |
skin | 4 studies | 43% ± 26% | |
breast | 4 studies | 40% ± 12% | |
placenta | 3 studies | 30% ± 2% | |
adrenal gland | 3 studies | 42% ± 22% | |
esophagus | 3 studies | 25% ± 6% | |
thymus | 3 studies | 26% ± 3% | |
brain | 3 studies | 30% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 15581.41 | 576 / 578 | 95% | 433.97 | 1092 / 1155 |
breast | 96% | 12613.74 | 440 / 459 | 95% | 296.78 | 1059 / 1118 |
bladder | 95% | 8347.67 | 20 / 21 | 95% | 874.31 | 478 / 504 |
skin | 96% | 11202.69 | 1742 / 1809 | 86% | 832.42 | 406 / 472 |
uterus | 83% | 5159.01 | 141 / 170 | 92% | 395.80 | 423 / 459 |
thymus | 84% | 4424.94 | 551 / 653 | 89% | 593.75 | 541 / 605 |
intestine | 83% | 5568.93 | 798 / 966 | 86% | 280.88 | 455 / 527 |
esophagus | 85% | 5822.95 | 1230 / 1445 | 62% | 114.81 | 113 / 183 |
prostate | 75% | 4876.41 | 183 / 245 | 56% | 88.64 | 282 / 502 |
kidney | 42% | 1938.24 | 37 / 89 | 79% | 178.92 | 709 / 901 |
stomach | 37% | 1898.75 | 132 / 359 | 83% | 258.61 | 238 / 286 |
ovary | 12% | 547.54 | 22 / 180 | 94% | 470.81 | 403 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 498.82 | 29 / 29 |
ureter | 0% | 0 | 0 / 0 | 100% | 636.37 | 1 / 1 |
adipose | 99% | 16763.91 | 1190 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 19511.29 | 1317 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 4% | 146.05 | 14 / 328 | 94% | 866.70 | 167 / 178 |
tonsil | 0% | 0 | 0 / 0 | 98% | 257.81 | 44 / 45 |
spleen | 97% | 9549.19 | 234 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 35498.33 | 779 / 929 | 0% | 0 | 0 / 0 |
heart | 62% | 2858.87 | 533 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 28% | 1006.34 | 73 / 258 | 30% | 118.23 | 70 / 230 |
liver | 1% | 46.80 | 2 / 226 | 31% | 61.08 | 125 / 406 |
muscle | 27% | 1375.12 | 218 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 23% | 82.71 | 18 / 80 |
brain | 0% | 5.37 | 4 / 2642 | 20% | 37.41 | 143 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001837 | Biological process | epithelial to mesenchymal transition |
GO_0050918 | Biological process | positive chemotaxis |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0042802 | Molecular function | identical protein binding |
GO_0046914 | Molecular function | transition metal ion binding |
GO_0042056 | Molecular function | chemoattractant activity |
GO_0048306 | Molecular function | calcium-dependent protein binding |
GO_0003723 | Molecular function | RNA binding |
GO_0050786 | Molecular function | RAGE receptor binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | S100A4 |
Protein name | Protein S100-A4 (Calvasculin) (Metastasin) (Placental calcium-binding protein) (Protein Mts1) (S100 calcium-binding protein A4) |
Synonyms | CAPL MTS1 |
Description | FUNCTION: Calcium-binding protein that plays a role in various cellular processes including motility, angiogenesis, cell differentiation, apoptosis, and autophagy . Increases cell motility and invasiveness by interacting with non-muscle myosin heavy chain (NMMHC) IIA/MYH9 . Mechanistically, promotes filament depolymerization and increases the amount of soluble myosin-IIA, resulting in the formation of stable protrusions facilitating chemotaxis (By similarity). Modulates also the pro-apoptotic function of TP53 by binding to its C-terminal transactivation domain within the nucleus and reducing its protein levels . Within the extracellular space, stimulates cytokine production including granulocyte colony-stimulating factor and CCL24 from T-lymphocytes (By similarity). In addition, stimulates T-lymphocyte chemotaxis by acting as a chemoattractant complex with PGLYRP1 that promotes lymphocyte migration via CCR5 and CXCR3 receptors . . |
Accessions | ENST00000368715.5 ENST00000354332.8 ENST00000368714.1 P26447 ENST00000368716.9 |